0
-
01/04/2022 PLASMINCURRENT PROJECTS PLASMIN April 2022 - December 2023 Reference No.: ZL-2022/00789 and ZL-2023/00028 Call for...
-
01/04/2022 ITEASCURRENT PROJECTS ITEAS April 2022- December 2024 Reference no: ZE-2022/00021 Call: HAZITEK ESTRATEGICO 2022 Project...
-
31/05/2021 Cardiva expands its business by acquiring a stake in the biopharmaceutical company HistocellThe company has decided to join one of the most renowned Spanish companies in the...
-
08/02/2021 Histocell and Cardiva join forces to introduce the innovative wound care product Reoxcare throughout the Spanish healthcare system.The Basque biopharmaceutical company Histocell and the company Cardiva join forces to introduce the innovative...
-
10/01/2021 Technological cosmeticsTEKNOPOLIS - EITB The Basque company Histocell researches the world of dermocosmetics, bringing together medicine...
-
17/12/2020 Histocell successfully completes the clinical safety phase of its cell therapy drug HC016 for the treatment of acute respiratory distress caused by covid-19Histocell has successfully completed phase I of the clinical trial of the cell therapy drug...
-
01/09/2020 Histocell joins forces with seven companies in the Bio-Health area to launch the IMABI projectEight Basque companies, as well as various agents of the Basque Science, Technology and Innovation...
-
01/06/2020 HEALIKICKCURRENT PROJECTS HEALIKICK “A COMBINED ATMP STRATEGY TO SUPPLEMENT CRITICAL SIZED BONE FRACTURE HEALING” Grant...
-
01/06/2020 BIO3DCURRENT PROJECTS BIO3D Reference No: ZE-2020/00021 Call: HAZITEK ESTRATEGICO 2020 Project co-financed by the Basque...
- 1
- 2